University of Iowa
Iowa City, Iowa, 52242, United States
NCT Number: NCT06157580
Otherwise healthy women who develop preeclampsia during pregnancy are more likely to develop and die of cardiovascular disease later in life. The reason why this occurs is unclear but may be related to impaired endothelial function and dysregulation of the angiotensin system that occurs during preeclampsia and persists postpartum, despite the remission of clinical symptoms. The purpose of this investigation is to determine the mechanisms contributing to this lasting blood vessel damage caused by reduced endothelial function in women who have had preeclampsia compared to women who had a healthy pregnancy. Identification of these mechanisms and treatment strategies may lead to better clinical management of cardiovascular disease risk in these women.
The purpose of this study is to examine differences in the microvascular balance of angiotensin II receptors women who have had preeclampsia. This will help the investigators better understand the mechanisms of dysregulated angiotensin II receptors in formerly preeclamptic women, and how activation or inhibition of these receptors may restore microvascular function.
In this study, the investigators use the blood vessels in the skin as a representative vascular bed for examining mechanisms of microvascular dysfunction in humans. Using a minimally invasive technique (intradermal microdialysis for the local delivery of pharmaceutical agents) the investigators examine the blood vessels in a dime-sized area of the skin.
Looking for future studies?
Notify Me18 year–45 year
Female
Interventional
Early Phase 1
Iowa City, Iowa, 52242, United States
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
differences in vasodilation to compound 21 in the skin between groups
differences in vasoconstriction to angiotensin II in the skin between groups
Time frame: at the study visit, an average of 4 hours
cutaneous vascular vasodilator responses to compound 21 perfusion in lactated Ringer's and losartan treated microdialysis sites
Time frame: at the study visit, an average of 4 hours
cutaneous vascular vasoconstrictor responses to angiotensin II perfusion in lactated Ringer's and PD-123319 treated microdialysis sites
Anna Stanhewicz, PhD
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05802940
Aspirin, Behavior
Danville, Pennsylvania, United States
View Trial DetailsNCT07717931
Cardiovascular Diseases, Female Urogenital Diseases and Pregnancy Complications
Multan, Punjab Province, Pakistan
View Trial DetailsNCT07265336
Female Urogenital Diseases and Pregnancy Complications, Hypertension, Pregnancy-Induced
Panama City, Provincia de Panamá, Panama
View Trial DetailsNCT07040696
Acute Kidney Injury, Female Urogenital Diseases
Cairo, Giza Governorate, Egypt
View Trial Details